ArticleBioinformation2026
Comparative evaluation of remineralisation potential using BioHAP, CPP-ACP and Enamelon on root dentin: An
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Root caries and cervical dentin hypersensitivity affect older adults with gingival recession, requiring effective remineralisation strategies for root dentin preservation. Therefore, it is of interest to compare remineralisation potential of BioHAP, CPP-ACP and Enamelon on artificially demineralised root dentin from 60 extracted premolars using a 28-day pH cycling protocol. All agents significantly increased microhardness versus control (p<0.001), with BioHAP achieving superior recovery at 68.42±7.83% compared to other groups. SEM analysis confirmed BioHAP's enhanced mineral deposition and dentinal tubular occlusion, demonstrating superior structural repair capabilities. These findings advance restorative dentistry by establishing BioHAP as the optimal commercial agent for root dentin remineralisation and hypersensitivity management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.